Mark Newman - Dec 2, 2021 Form 4 Insider Report for Chemours Co (CC)

Role
President and CEO, Director
Signature
/s/ Pauletta Brown, Attorney-in-Fact
Stock symbol
CC
Transactions as of
Dec 2, 2021
Transactions value $
-$393,555
Form type
4
Date filed
12/3/2021, 04:05 PM
Previous filing
Aug 30, 2021
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CC Common Stock Options Exercise $632K +34.3K +23.55% $18.45 180K Dec 2, 2021 Direct F1, F2
transaction CC Common Stock Sale -$1.03M -34.3K -19.06% $29.94 145K Dec 2, 2021 Direct F1, F2, F3
holding CC Common Stock 2.48K Dec 2, 2021 Reporting person's children

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Stock Option (Right to Buy) Options Exercise $0 -34.3K -100% $0.00* 0 Dec 2, 2021 Common Stock 34.3K $18.45 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021.
F2 Includes directly owned shares, restricted stock units, and dividend equivalent units.
F3 Shares were sold in multiple transactions at prices ranging from $29.51 to $30.16.
F4 Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.